Director and her Team

2026-2022

1. Moore A, Kane E, Teras LR, Machiela MJ, Arias J, Panagiotou OA, et al. (2026). Genetically determined body mass index is associated with diffuse large B-cell lymphoma in polygenic and Mendelian randomization analyses. Int J Cancer. 158(1): 45-59. https://doi.org/10.1002/ijc.70039 PMID: 40910475
2. Aglago EK, Ramos I, Keski-Rahkonen P, Chatziioannou C, Freisling H, Fedirko V, et al. (2025). Alcohol and smoking habits in association with hepatocellular carcinoma risk. Int J Cancer. 157(4): 644-657. https://doi.org/10.1002/ijc.35401 PMID: 40098437
3. Al Nahas A, Yammine Ghantous S, Morales Berstein F, Cakmak EK, Biessy C, Nicolas G, et al. (2025). Associations between degree of food processing and colorectal cancer risk in a large-scale European cohort. Int J Cancer. 157(2): 260-276. https://doi.org/10.1002/ijc.35361 PMID: 39921517
4. Almanza-Aguilera E, Guananga-Alvarez D, Benavente Y, Nieters A, Besson C, Saberi Hosnijeh F, et al. (2025). Intake of total, classes, and subclasses of (poly)phenols and risk of lymphoid neoplasms: a prospective analysis in the EPIC cohort. Br J Cancer. 133(12): 1864-1871. https://doi.org/10.1038/s41416-025-03228-6 PMID: 41044175
5. Berden J, Chimera B, Hanley-Cook GT, Cakmak EK, Vineis P, Nicolas G, et al. (2025). Biodiverse diets present co-benefits for greenhouse gas emissions, land use, mortality rates and nutritional adequacy in Europe. Nat Food. 6(9): 857-867. https://doi.org/10.1038/s43016-025-01214-y PMID: 40835792
6. Berden J, Hanley-Cook GT, Chimera B, Aune D, Pinho MGM, Nicolas G, et al. (2025). Quantifying the environmental and food biodiversity impacts of ultra-processed foods: evidence from the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr. 28(1): e164. https://doi.org/10.1017/S1368980025101067 PMID: 40931427
7. Brantley KD, Jones ME, Tamimi RM, Rosner BA, Kraft P, Nichols HB, et al. (2025). Development and validation of a risk prediction model for premenopausal breast cancer in 19 cohorts. Breast Cancer Res. 27(1): 67. https://doi.org/10.1186/s13058-025-02031-8 PMID: 40312753
8. Chung HF, Hayashi K, Dobson AJ, Sandin S, Ideno Y, Hardy R, et al. (2025). Association between endometriosis and type and age of menopause: a pooled analysis of 279 948 women from five cohort studies. Hum Reprod. 40(6): 1210-1219. https://doi.org/10.1093/humrep/deaf068 PMID: 40304605
9. Grenville ZS, Noor U, Rinaldi S, Gunter MJ, Ferrari P, Agnoli C, et al. (2025). Perturbations in the blood metabolome up to a decade before prostate cancer diagnosis in 4387 matched case-control sets from the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 156(5): 943-952. https://doi.org/10.1002/ijc.35208 PMID: 39378119
10. Hasanpour-Heidari S, Semnani S, Fazel A, Naeimi-Tabiei M, Mehrjerdian M, Sedaghat S, et al. (2025). Risk of Second Primary Neoplasms Among Cancer Survivors: A Population-Based, Cohort Study in Golestan Province, Northern Iran, 2004-2019. Cancer Med. 14(10): e70926. https://doi.org/10.1002/cam4.70926 PMID: 40391756
11. Katzke VA, Dutta S, Rasokat A, Archibugi L, Capurso G, Peduzzi G, et al. (2025). Sex Disparities and Female Reproductive and Hormonal Factors Associated with Risk of Pancreatic Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort. Cancers (Basel). 17(14). https://doi.org/10.3390/cancers17142275 PMID: 40723159
12. Koc Cakmak E, Al Nahas A, Chimera B, Hanley-Cook G, Berden J, Fardet A, et al. (2025). The 3V score and joint associations of low ultra-processed food, biodiverse and plant-based diets on colorectal cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC) study. EClinicalMedicine. 90: 103662. https://doi.org/10.1016/j.eclinm.2025.103662 PMID: 41438976
13. Koczkodaj P, Damianos M, Jagielska B, Weiderpass E, Schuz J (2025). In the framework of the EU Trio Presidency-supporting the European Code Against Cancer. Lancet Reg Health Eur. 57: 101451. https://doi.org/10.1016/j.lanepe.2025.101451 PMID: 40917995
14. Macciotta A, Sacerdote C, Giachino C, Di Girolamo C, Franco M, van der Schouw YT, et al. (2025). Examining causal relationships between educational attainment and type 2 diabetes using genetic analysis: findings from the EPIC-InterAct study through Mendelian randomisation. J Epidemiol Community Health. 79(5): 373-379. https://doi.org/10.1136/jech-2024-222734 PMID: 39658133
15. Mandle HB, Jenab M, Gunter MJ, Tjonneland A, Olsen A, Dahm CC, et al. (2025). Inflammation and gut barrier function-related genes and colorectal cancer risk in western European populations. Mutagenesis. 40(1): 48-60. https://doi.org/10.1093/mutage/geae008 PMID: 38441165
16. Matta K, Viallon V, Chatziioannou AC, Robinot N, Wedekind R, Dahm CC, et al. (2025). Can serum metabolic signatures inform on the relationship between healthy lifestyle and colon cancer risk? Cancer Metab. 13(1): 30. https://doi.org/10.1186/s40170-025-00388-0 PMID: 40524238
17. Naudin S, Wang M, Dimou N, Ebrahimi E, Genkinger J, Adami HO, et al. (2025). Alcohol intake and pancreatic cancer risk: An analysis from 30 prospective studies across Asia, Australia, Europe, and North America. PLoS Med. 22(5): e1004590. https://doi.org/10.1371/journal.pmed.1004590 PMID: 40392909
18. Papadimitriou N, Kazmi N, Tsilidis KK, Richmond RC, Lynch BM, Bendinelli B, et al. (2025). Identifying Metabolomic Mediators of the Physical Activity and Colorectal Cancer Relationship. Cancer Epidemiol Biomarkers Prev. 34(4): 578-587. https://doi.org/10.1158/1055-9965.EPI-24-1390 PMID: 39883068
19. Park JY, Van Puyvelde H, Regazzetti L, Clasen JL, Heath AK, Eussen S, et al. (2025). Association Between Dietary Intake and Blood Concentrations of One-Carbon-Metabolism-Related Nutrients in European Prospective Investigation into Cancer and Nutrition. Nutrients. 17(12): 19. https://doi.org/10.3390/nu17121970 PMID: 40573081
20. Perrier F, Ahimbisibwe A, Ghiasvand R, Rueegg CS, Green AC, Borch KB, et al. (2025). Physical activity and mortality in melanoma patients within the Norwegian Women and Cancer study (NOWAC). Int J Cancer. 157(5): 846-857. https://doi.org/10.1002/ijc.35430 PMID: 40181554
21. Reichmann R, Nimptsch K, Pischon T, Gunter MJ, Jenab M, Eriksen AK, et al. (2025). Sex- and site-specific associations of circulating lipocalin 2 and incident colorectal cancer: Results from the EPIC cohort. Int J Cancer. 156(5): 930-942. https://doi.org/10.1002/ijc.35205 PMID: 39511728
22. Schoemaker MJ, Ellington T, Nichols HB, Wright LB, Jones ME, O’Brien KM, et al. (2025). Central and peripheral adiposity and premenopausal breast cancer risk: a pooled analysis of 440,179 women. Breast Cancer Res. 27(1): 55. https://doi.org/10.1186/s13058-025-01995-x PMID: 40234955
23. Sheikh M, Weiderpass E (2025). Lung cancer screening in Europe: a golden opportunity to address tobacco use through scalable, WHO-guided cessation interventions. Eur Respir J. 65(6): 5. https://doi.org/10.1183/13993003.00124-2025 PMID: 40537166
24. Shi F, Chowdhury R, Sofianopoulou E, Koulman A, Sun L, Steur M, et al. (2025). Association of circulating fatty acids with cardiovascular disease risk: analysis of individual-level data in three large prospective cohorts and updated meta-analysis. Eur J Prev Cardiol. 32(3): 233-246. https://doi.org/10.1093/eurjpc/zwae315 PMID: 39365172
25. Tschiderer L, Peters SAE, van der Schouw YT, Burgess S, Luijken J, Bijmolt C, et al. (2025). Reassessing the association between age at menarche and cardiovascular disease: observational and Mendelian randomization analyses. Eur J Prev Cardiol. 32(10): 857-866. https://doi.org/10.1093/eurjpc/zwaf051 PMID: 40099743
26. Tschiderer L, Peters SAE, van der Schouw YT, Burgess S, Luijken J, Bijmolt C, et al. (2025). Reassessing the association between age at menarche and cardiovascular disease: observational and Mendelian randomization analyses. Eur J Prev Cardiol. 32(10): 857-866. https://doi.org/10.1093/eurjpc/zwaf051 PMID: 40099743
27. Almanza-Aguilera E, Martinez-Huelamo M, Lopez-Hernandez Y, Guinon-Fort D, Guadall A, Cruz M, et al. (2024). Prediagnostic Plasma Nutrimetabolomics and Prostate Cancer Risk: A Nested Case-Control Analysis Within the EPIC Study. Cancers (Basel). 16(23): 4116. https://doi.org/10.3390/cancers16234116 PMID: 39682302
28. Beigrezaei S, Dianati M, Salehi-Abargouei A, Fararouei M, Akbari-Beni A, Brinkman M, et al. (2024). The association between animal protein, plant protein, and their substitution with bladder cancer risk: a pooled analysis of 10 cohort studies. Eur J Nutr. 64(1): 55. https://doi.org/10.1007/s00394-024-03551-3 PMID: 39718625
29. Botteri E, Peveri G, Berstad P, Bagnardi V, Hoff G, Heath AK, et al. (2024). Lifestyle changes in middle age and risk of cancer: evidence from the European Prospective Investigation into Cancer and Nutrition. Eur J Epidemiol. 39(2): 147-159. https://doi.org/10.1007/s10654-023-01059-4 PMID: 38180593
30. Cariolou M, Christakoudi S, Gunter MJ, Key T, Perez-Cornago A, Travis R, et al. (2024). Adiposity assessed close to diagnosis and prostate cancer prognosis in the EPIC study. JNCI Cancer Spectr. 8(5): 12. https://doi.org/10.1093/jncics/pkae070 PMID: 39180334
31. Cavalli F, Mikkelsen B, Weiderpass E, Sullivan R, Jaffray D, Gospodarowicz M (2024). World Oncology Forum amplifies its appeal in global fight against cancer. Lancet Oncol. 25(2): 170-174. https://doi.org/10.1016/S1470-2045(24)00010-X PMID: 38301688
32. Deschasaux-Tanguy M, Huybrechts I, Julia C, Hercberg S, Sarda B, Fialon M, et al. (2024). Nutritional quality of diet characterized by the Nutri-Score profiling system and cardiovascular disease risk: a prospective study in 7 European countries. Lancet Reg Health Eur. 46: 101006. https://doi.org/10.1016/j.lanepe.2024.101006 PMID: 39529812
33. Dicken SJ, Dahm CC, Ibsen DB, Olsen A, Tjonneland A, Louati-Hajji M, et al. (2024). Food consumption by degree of food processing and risk of type 2 diabetes mellitus: a prospective cohort analysis of the European Prospective Investigation into Cancer and Nutrition (EPIC). Lancet Reg Health Eur. 46: 101043. https://doi.org/10.1016/j.lanepe.2024.101043 PMID: 39529810
34. Dobson AJ, Xu Z, Wilson LF, Chung HF, Sandin S, Van der Schouw YT, et al. (2024). Menopause age and type and dementia risk: a pooled analysis of 233 802 women. Age Ageing. 53(11): afae254. https://doi.org/10.1093/ageing/afae254 PMID: 39562342
35. Fiolet T, Nicolas G, Casagrande C, Horvath Z, Frenoy P, Weiderpass E, et al. (2024). Dietary intakes of dioxins and polychlorobiphenyls (PCBs) and mortality: EPIC cohort study in 9 European countries. Int J Hyg Environ Health. 255: 114287. https://doi.org/10.1016/j.ijheh.2023.114287 PMID: 37989047
36. Ghasemi-Kebria F, Fazel A, Semnani S, Etemadi A, Naeimi-Tabiei M, Hasanpour-Heidari S, et al. (2024). Breast cancer incidence trends in Golestan, Iran: An age-period-cohort analysis by ethnic region, 2004-2018. Cancer Epidemiol. 89: 102525. https://doi.org/10.1016/j.canep.2024.102525 PMID: 38228040
37. Hadji M, Rashidian H, Marzban M, Rezaianzadeh A, Ansari-Moghaddam A, Bakhshi M, et al. (2024). Unveiling an Association between Waterpipe Smoking and Bladder Cancer Risk: A Multicenter Case-Control Study in Iran. Cancer Epidemiol Biomarkers Prev. 33(4): 509-515. https://doi.org/10.1158/1055-9965.EPI-23-0773 PMID: 38180357
38. Hickey M, Basu P, Sassarini J, Stegmann ME, Weiderpass E, Nakawala Chilowa K, et al. (2024). Managing menopause after cancer. Lancet. 403(10430): 984-996. https://doi.org/10.1016/S0140-6736(23)02802-7 PMID: 38458217
39. Li J, Roshelli Baker J, Aglago EK, Zhao Z, Jiao L, Freisling H, et al. (2024). Pre-diagnostic plasma advanced glycation end-products and soluble receptor for advanced glycation end-products and mortality in colorectal cancer patients. Int J Cancer. 155(11): 1982-1995. https://doi.org/10.1002/ijc.35114 PMID: 39057841
40. Liang C, Chung HF, Dobson A, Sandin S, Weiderpass E, Mishra GD (2024). Female reproductive histories and the risk of chronic obstructive pulmonary disease. Thorax. 79(6): 508-514. https://doi.org/10.1136/thorax-2023-220388 PMID: 38350732
41. Liang C, Dobson AJ, Chung HF, van der Schouw YT, Sandin S, Weiderpass E, et al. (2024). Association of infertility and recurrent pregnancy loss with the risk of dementia. Eur J Epidemiol. 39(7): 785-793. https://doi.org/10.1007/s10654-024-01135-3 PMID: 38888679
42. Matta K, Viallon V, Botteri E, Peveri G, Dahm C, Nannsen AO, et al. (2024). Healthy lifestyle change and all-cause and cancer mortality in the European Prospective Investigation into Cancer and Nutrition cohort. BMC Med. 22(1): 210. https://doi.org/10.1186/s12916-024-03362-7 PMID: 38807179
43. Mayen AL, Sabra M, Aglago EK, Perlemuter G, Voican C, Ramos I, et al. (2024). Hepatic steatosis, metabolic dysfunction and risk of mortality: findings from a multinational prospective cohort study. BMC Med. 22(1): 221. https://doi.org/10.1186/s12916-024-03366-3 PMID: 38825687
44. Mendes-Santos C, Nobrega C, Quinta-Gomes AL, Weiderpass E, Santana R, Andersson G (2024). Validation of the Portuguese version of the supportive care needs survey short-form questionnaire (SCNS-SF34-Pt) and the breast cancer supplementary module (SCNS-BR8-Pt). J Psychosoc Oncol. 42(4): 486-505. https://doi.org/10.1080/07347332.2023.2282015 PMID: 37975563
45. Meng W, Leung JW, Wang Z, Li Q, Zhang L, Zhang K, et al. (2024). Safety of high-carbohydrate fluid diet 2 h versus overnight fasting before non-emergency endoscopic retrograde cholangiopancreatography: A single-blind, multicenter, randomized controlled trial. Chin Med J (Engl). 137(12): 1437-1446. https://doi.org/10.1097/CM9.0000000000002820 PMID: 37620294
46. Morales-Berstein F, Biessy C, Viallon V, Goncalves-Soares A, Casagrande C, Hemon B, et al. (2024). Ultra-processed foods, adiposity and risk of head and neck cancer and oesophageal adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition study: a mediation analysis. Eur J Nutr. 63(2): 377-396. https://doi.org/10.1007/s00394-023-03270-1 PMID: 37989797
47. O’Grady TJ, Rinaldi S, Michels KA, Adami HO, Buring JE, Chen Y, et al. (2024). Association of hormonal and reproductive factors with differentiated thyroid cancer risk in women: a pooled prospective cohort analysis. Int J Epidemiol. 53(1). https://doi.org/10.1093/ije/dyad172 PMID: 38110618
48. Peltonen J, Nikkila R, Al-Samadi A, Makitie A, Martinsen JI, Kjaerheim K, et al. (2024). Occupation and tongue cancer in Nordic countries. BMC Oral Health. 24(1): 506. https://doi.org/10.1186/s12903-024-04172-2 PMID: 38685000
49. Pham TT, Nimptsch K, Aleksandrova K, Jenab M, Fedirko V, Wu K, et al. (2024). Pre-diagnostic circulating resistin concentrations and mortality among individuals with colorectal cancer: Results from the European Prospective Investigation into Cancer and Nutrition study. Int J Cancer. 154(9): 1596-1606. https://doi.org/10.1002/ijc.34830 PMID: 38200695
50. Rashidian H, Hadji M, Ansari-Moghaddam A, Bakhshi M, Nejatizadeh A, Marzban M, et al. (2024). Association between waterpipe smoking and lung cancer: a multicentre case-control study in Iran. Public Health. 231: 166-172. https://doi.org/10.1016/j.puhe.2024.03.008 PMID: 38701659
51. Rimal R, Robsahm TE, Green AC, Ghiasvand R, Rueegg CS, Bassarova A, et al. (2024). Trends in Invasive Melanoma Thickness in Norway, 1983-2019. Acta Derm Venereol. 104: adv26110. https://doi.org/10.2340/actadv.v104.26110 PMID: 39221835
52. Ringborg U, von Braun J, Celis J, Baumann M, Berns A, Eggermont A, et al. (2024). Strategies to decrease inequalities in cancer therapeutics, care and prevention: Proceedings on a conference organized by the Pontifical Academy of Sciences and the European Academy of Cancer Sciences, Vatican City, February 23-24, 2023. Mol Oncol. 18(2): 245-279. https://doi.org/10.1002/1878-0261.13575 PMID: 38135904
53. Timmins IR, Jones ME, O’Brien KM, Adami HO, Aune D, Baglietto L, et al. (2024). International Pooled Analysis of Leisure-Time Physical Activity and Premenopausal Breast Cancer in Women From 19 Cohorts. J Clin Oncol. 42(8): 927-939. https://doi.org/10.1200/JCO.23.01101 PMID: 38079601
54. Tong TYN, Clarke R, Schmidt JA, Huybrechts I, Noor U, Forouhi NG, et al. (2024). Dietary amino acids and risk of stroke subtypes: a prospective analysis of 356,000 participants in seven European countries. Eur J Nutr. 63(1): 209-220. https://doi.org/10.1007/s00394-023-03251-4 PMID: 37804448
55. Viallon V, Freisling H, Matta K, Nannsen AO, Dahm CC, Tjonneland A, et al. (2024). On the use of the healthy lifestyle index to investigate specific disease outcomes. Sci Rep. 14(1): 16330. https://doi.org/10.1038/s41598-024-66772-w PMID: 39009699
56. Von Holle A, Adami HO, Baglietto L, Berrington de Gonzalez A, Bertrand KA, Blot W, et al. (2024). BMI and breast cancer risk around age at menopause. Cancer Epidemiol. 89: 102545. https://doi.org/10.1016/j.canep.2024.102545 PMID: 38377945
57. Zheng JS, Steur M, Imamura F, Freisling H, Johnson L, van der Schouw YT, et al. (2024). Dietary intake of plant- and animal-derived protein and incident cardiovascular diseases: the pan-European EPIC-CVD case-cohort study. Am J Clin Nutr. 119(5): 1164-1174. https://doi.org/10.1016/j.ajcnut.2024.03.006 PMID: 38479550
58. Ahimbisibwe A, Valberg M, Green AC, Ghiasvand R, Rueegg CS, Rimal R, et al. (2023). Nevus Count, Pigmentary Characteristics, and Melanoma-specific Mortality among Norwegian Women with Melanoma >1.0 mm Thick. Acta Derm Venereol. 103: adv4403. https://doi.org/10.2340/actadv.v103.4403 PMID: 37014267
59. Ali M, Nusselder W, Weiderpass E, Corbex M, Bray F, Vaccarella S (2023). Inequities in cancer outcomes. Bull World Health Organ. 101(9): 550. https://doi.org/10.2471/BLT.23.290661 PMID: 37663873
60. Allione A, Viberti C, Cotellessa I, Catalano C, Casalone E, Cugliari G, et al. (2023). Blood cell DNA methylation biomarkers in preclinical malignant pleural mesothelioma: The EPIC prospective cohort. Int J Cancer. 152(4): 725-737. https://doi.org/10.1002/ijc.34339 PMID: 36305648
61. Almanza-Aguilera E, Guinon-Fort D, Perez-Cornago A, Martinez-Huelamo M, Andres-Lacueva C, Tjonneland A, et al. (2023). Intake of the Total, Classes, and Subclasses of (Poly)Phenols and Risk of Prostate Cancer: A Prospective Analysis of the EPIC Study. Cancers (Basel). 15(16). https://doi.org/10.3390/cancers15164067 PMID: 37627095
62. Baumann M, Celis J, Ringborg U, Heitor M, Berns A, Albreht T, et al. (2023). Engaging European society at the forefront of cancer research and care: How discussions at the 5(th) Gago Conference on European Science policy led to the Heidelberg Manifesto: How discussions at the 5(th) Gago Conference on European Science policy led to the Heidelberg Manifesto. Mol Oncol. 17(6): 925-945. https://doi.org/10.1002/1878-0261.13423 PMID: 36938773
63. Berndt SI, Vijai J, Benavente Y, Camp NJ, Nieters A, Wang Z, et al. (2023). Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes. Leukemia. 37(10): 2142-2142. https://doi.org/10.1038/s41375-023-01978-x PMID: 37666943
64. Bonet C, Crous-Bou M, Tsilidis KK, Gunter MJ, Kaaks R, Schulze MB, et al. (2023). The association between body fatness and mortality among breast cancer survivors: results from a prospective cohort study. Eur J Epidemiol. 38(5): 545-557. https://doi.org/10.1007/s10654-023-00979-5 PMID: 36988840
65. Botteri E, Peveri G, Berstad P, Bagnardi V, Chen SLF, Sandanger TM, et al. (2023). Changes in Lifestyle and Risk of Colorectal Cancer in the European Prospective Investigation Into Cancer and Nutrition. Am J Gastroenterol. 118(4): 702-711. https://doi.org/10.14309/ajg.0000000000002065 PMID: 36227801
66. Castaneda J, Gil-Lespinard M, Almanza-Aguilera E, Llaha F, Gomez JH, Bondonno N, et al. (2023). Association between classes and subclasses of polyphenol intake and 5-year body weight changes in the EPIC-PANACEA study. Obesity (Silver Spring). 31(4): 1146-1158. https://doi.org/10.1002/oby.23689 PMID: 36693804
67. Castro-Espin C, Bonet C, Crous-Bou M, Katzke V, Le Cornet C, Jannasch F, et al. (2023). Dietary patterns related to biological mechanisms and survival after breast cancer diagnosis: results from a cohort study. Br J Cancer. 128(7): 1301-1310. https://doi.org/10.1038/s41416-023-02169-2 PMID: 36737658
68. Castro-Espin C, Bonet C, Crous-Bou M, Nadal-Zaragoza N, Tjonneland A, Mellemkjaer L, et al. (2023). Association of Mediterranean diet with survival after breast cancer diagnosis in women from nine European countries: results from the EPIC cohort study. BMC Med. 21(1): 225. https://doi.org/10.1186/s12916-023-02934-3 PMID: 37365585
69. Christakoudi S, Tsilidis KK, Dossus L, Rinaldi S, Weiderpass E, Antoniussen CS, et al. (2023). A body shape index (ABSI) is associated inversely with post-menopausal progesterone-receptor-negative breast cancer risk in a large European cohort. BMC Cancer. 23(1): 562. https://doi.org/10.1186/s12885-023-11056-1 PMID: 37337133
70. Chung FF, Maldonado SG, Nemc A, Bouaoun L, Cahais V, Cuenin C, et al. (2023). Buffy coat signatures of breast cancer risk in a prospective cohort study. Clin Epigenetics. 15(1): 102. https://doi.org/10.1186/s13148-023-01509-6 PMID: 37309009
71. Chung HF, Dobson AJ, Hayashi K, Hardy R, Kuh D, Anderson DJ, et al. (2023). Ethnic Differences in the Association Between Age at Natural Menopause and Risk of Type 2 Diabetes Among Postmenopausal Women: A Pooled Analysis of Individual Data From 13 Cohort Studies. Diabetes Care. 46(11): 2024-2034. https://doi.org/10.2337/dc23-1209 PMID: 37747341
72. Clasen JL, Mabunda R, Heath AK, Kaaks R, Katzke V, Schulze MB, et al. (2023). Reproductive and hormonal factors and risk of renal cell carcinoma among women in the European Prospective Investigation into Cancer and Nutrition. Cancer Med. 12(14): 15588-15600. https://doi.org/10.1002/cam4.6207 PMID: 37269199
73. Ersoy Guller Z, Harewood RN, Weiderpass E, Huybrechts I, Jenab M, Huerta JM, et al. (2023). Diet and lifestyle in relation to small intestinal cancer risk: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control. 34(10): 927-937. https://doi.org/10.1007/s10552-023-01731-w PMID: 37330982
74. Fontvieille E, Viallon V, Recalde M, Cordova R, Jansana A, Peruchet-Noray L, et al. (2023). Body mass index and cancer risk among adults with and without cardiometabolic diseases: evidence from the EPIC and UK Biobank prospective cohort studies. BMC Med. 21(1): 418. https://doi.org/10.1186/s12916-023-03114-z PMID: 37993940
75. Ghasemi-Kebria F, Jafari-Delouie N, Semnani S, Fazel A, Etemadi A, Norouzi A, et al. (2023). Colorectal cancer incidence trends in Golestan, Iran: An age-period-cohort analysis 2004-2018. Cancer Epidemiol. 86: 102415. https://doi.org/10.1016/j.canep.2023.102415 PMID: 37442047
76. Ghasemi-Kebria F, Semnani S, Fazel A, Etemadi A, Amiriani T, Naeimi-Tabiei M, et al. (2023). Esophageal and gastric cancer incidence trends in Golestan, Iran: An age-period-cohort analysis 2004 to 2018. Int J Cancer. 153(1): 73-82. https://doi.org/10.1002/ijc.34518 PMID: 36943026
77. Hadji M, Marzban M, Rashidian H, Naghibzadeh-Tahami A, Gholipour M, Mohebbi E, et al. (2023). Opium use and risk of colorectal cancer: a multi-center case-referent study in Iran. Acta Oncol. 62(12): 1661-1668. https://doi.org/10.1080/0284186X.2023.2276326 PMID: 37934078
78. Heikkinen S, Demers PA, Hansen J, Jakobsen J, Kjaerheim K, Lynge E, et al. (2023). Incidence of cancer among Nordic police officers. Int J Cancer. 152(6): 1124-1136. https://doi.org/10.1002/ijc.34311 PMID: 36196485
79. Karavasiloglou N, Hughes DJ, Murphy N, Schomburg L, Sun Q, Seher V, et al. (2023). Prediagnostic serum calcium concentrations and risk of colorectal cancer development in 2 large European prospective cohorts. Am J Clin Nutr. 117(1): 33-45. https://doi.org/10.1016/j.ajcnut.2022.10.004 PMID: 36789942
80. Koutros S, Kiemeney LA, Pal Choudhury P, Milne RL, Lopez de Maturana E, Ye Y, et al. (2023). Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights. Eur Urol. 84(1): 127-137. https://doi.org/10.1016/j.eururo.2023.04.020 PMID: 37210288
81. Laakso L, Jokelainen P, Houe H, Skjerve E, Hansen J, Lynge E, et al. (2023). No Excess Cancer Risk among Veterinarians in Denmark, Finland, Iceland, Norway, and Sweden after the 1980s. Cancers (Basel). 15(16). https://doi.org/10.3390/cancers15164079 PMID: 37627107
82. Lampousi AM, Carlsson S, Lofvenborg JE, Cabrera-Castro N, Chirlaque MD, Fagherazzi G, et al. (2023). Interaction between plasma phospholipid odd-chain fatty acids and GAD65 autoantibodies on the incidence of adult-onset diabetes: the EPIC-InterAct case-cohort study. Diabetologia. 66(8): 1460-1471. https://doi.org/10.1007/s00125-023-05948-x PMID: 37301794
83. Lecuyer L, Laouali N, Viallon V, Artaud F, Hebert JR, Shivappa N, et al. (2023). Associations between dietary inflammatory scores and biomarkers of inflammation in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Clin Nutr. 42(7): 1115-1125. https://doi.org/10.1016/j.clnu.2023.05.012 PMID: 37271707
84. Lukic M, Licaj I, Laaksonen MA, Weiderpass E, Borch KB, Rylander C (2023). The burden of colon cancer attributable to modifiable factors-The Norwegian Women and Cancer Study. Int J Cancer. 152(2): 195-202. https://doi.org/10.1002/ijc.34237 PMID: 36054722
85. Macciotta A, Catalano A, Giraudo MT, Weiderpass E, Ferrari P, Freisling H, et al. (2023). Mediating Role of Lifestyle Behaviors in the Association between Education and Cancer: Results from the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev. 32(1): 132-140. https://doi.org/10.1158/1055-9965.EPI-22-0777 PMID: 36306379
86. Mafra A, Bardot A, Charvat H, Weiderpass E, Soerjomataram I, Fregnani J (2023). Cancer survival in the northwestern of Sao Paulo State, Brazil: A population-based study. Cancer Epidemiol. 83: 102339. https://doi.org/10.1016/j.canep.2023.102339 PMID: 36863216
87. Mahamat-Saleh Y, Al-Rahmoun M, Severi G, Ghiasvand R, Veierod MB, Caini S, et al. (2023). Baseline and lifetime alcohol consumption and risk of skin cancer in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC). Int J Cancer. 152(3): 348-362. https://doi.org/10.1002/ijc.34253 PMID: 36053839
88. Mahamat-Saleh Y, Rinaldi S, Kaaks R, Biessy C, Gonzalez-Gil EM, Murphy N, et al. (2023). Metabolically defined body size and body shape phenotypes and risk of postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition. Cancer Med. 12(11): 12668-12682. https://doi.org/10.1002/cam4.5896 PMID: 37096432
89. Mao Z, Baker JR, Takeuchi M, Hyogo H, Tjonneland A, Eriksen AK, et al. (2023). Prediagnostic serum glyceraldehyde-derived advanced glycation end products and mortality among colorectal cancer patients. Int J Cancer. 152(11): 2257-2268. https://doi.org/10.1002/ijc.34449 PMID: 36715363
90. Mendes-Santos C, Campos T, Ferreira D, Weiderpass E, Santana R, Andersson G (2023). Breast Cancer Survivors’ Attitudes toward eMental Health: A Cross-Sectional Study. Healthcare (Basel). 11(13): 16. https://doi.org/10.3390/healthcare11131920 PMID: 37444755
91. Meyer A, Dong C, Casagrande C, Chan SSM, Huybrechts I, Nicolas G, et al. (2023). Food Processing and Risk of Crohn’s Disease and Ulcerative Colitis: A European Prospective Cohort Study. Clin Gastroenterol Hepatol. 21(6): 1607-1616 e1606. https://doi.org/10.1016/j.cgh.2022.09.031 PMID: 36243353
92. Perrier F, Robsahm TE, Ghiasvand R, Borch KB, Braaten T, Weiderpass E, et al. (2023). No association between physical activity and primary melanoma thickness in a cohort of Norwegian women. Br J Dermatol. 188(5): 670-690. https://doi.org/10.1093/bjd/ljac136 PMID: 36718120
93. Rashidian H, Hadji M, Gholipour M, Naghibzadeh-Tahami A, Marzban M, Mohebbi E, et al. (2023). Opium use and risk of lung cancer: A multicenter case-control study in Iran. Int J Cancer. 152(2): 203-213. https://doi.org/10.1002/ijc.34244 PMID: 36043555
94. Schmidt JA, Huybrechts I, Overvad K, Eriksen AK, Tjonneland A, Kaaks R, et al. (2023). Protein and amino acid intakes in relation to prostate cancer risk and mortality-A prospective study in the European Prospective Investigation into Cancer and Nutrition. Cancer Med. 12(4): 4725-4738. https://doi.org/10.1002/cam4.5289 PMID: 36148781
95. Schuz J, Espina C, Carvalho A, Maza M, Luciani S, Cazap E, et al. (2023). Latin America and the Caribbean Code Against Cancer 1st Edition: A landmark for cancer prevention in the region. Cancer Epidemiol. 86 Suppl 1: 102453. https://doi.org/10.1016/j.canep.2023.102453 PMID: 37852730
96. Sedlmeier AM, Viallon V, Ferrari P, Peruchet-Noray L, Fontvieille E, Amadou A, et al. (2023). Body shape phenotypes of multiple anthropometric traits and cancer risk: a multi-national cohort study. Br J Cancer. 128(4): 594-605. https://doi.org/10.1038/s41416-022-02071-3 PMID: 36460776
97. Spacirova Z, Kaptoge S, Garcia-Mochon L, Rodriguez Barranco M, Sanchez Perez MJ, Bondonno NP, et al. (2023). The cost-effectiveness of a uniform versus age-based threshold for one-off screening for prevention of cardiovascular disease. Eur J Health Econ. 24(7): 1033-1045. https://doi.org/10.1007/s10198-022-01533-y PMID: 36239877
98. Tschiderer L, Peters SAE, van der Schouw YT, van Westing AC, Tong TYN, Willeit P, et al. (2023). Age at Menopause and the Risk of Stroke: Observational and Mendelian Randomization Analysis in 204 244 Postmenopausal Women. J Am Heart Assoc. 12(18): e030280. https://doi.org/10.1161/JAHA.123.030280 PMID: 37681566
99. Van Sloten T, Valentin E, Climie RE, Deraz O, Weiderpass E, Jouven X, et al. (2023). Association of Midlife Cardiovascular Health and Subsequent Change in Cardiovascular Health With Incident Cancer. JACC CardioOncol. 5(1): 39-52. https://doi.org/10.1016/j.jaccao.2022.11.015 PMID: 36875895
100. Watts EL, Perez-Cornago A, Fensom GK, Smith-Byrne K, Noor U, Andrews CD, et al. (2023). Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis. Int J Epidemiol. 52(1): 71-86. https://doi.org/10.1093/ije/dyac124 PMID: 35726641
101. Wu Z, Trabert B, Guillemette C, Caron P, Bradwin G, Graubard BI, et al. (2023). Prediagnostic Hormone Levels and Risk of Testicular Germ Cell Tumors: A Nested Case-Control Study in the Janus Serum Bank. Cancer Epidemiol Biomarkers Prev. 32(11): 1564-1571. https://doi.org/10.1158/1055-9965.EPI-23-0772 PMID: 37619591
102. Yammine SG, Huybrechts I, Biessy C, Dossus L, Panico S, Sanchez MJ, et al. (2023). Dietary fatty acids and endometrial cancer risk within the European Prospective Investigation into Cancer and Nutrition. BMC Cancer. 23(1): 159. https://doi.org/10.1186/s12885-023-10611-0 PMID: 36797668
103. Zamora-Ros R, Cayssials V, Cleries R, Torrents M, Byrnes G, Weiderpass E, et al. (2023). Sweetened beverages are associated with a higher risk of differentiated thyroid cancer in the EPIC cohort: a dietary pattern approach. Eur J Nutr. 62(1): 105-114. https://doi.org/10.1007/s00394-022-02953-5 PMID: 35907037
104. Alcala K, Mariosa D, Smith-Byrne K, Nasrollahzadeh Nesheli D, Carreras-Torres R, Ardanaz Aicua E, et al. (2022). The relationship between blood pressure and risk of renal cell carcinoma. Int J Epidemiol. 51(4): 1317-1327. https://doi.org/10.1093/ije/dyac042 PMID: 35312764
105. Al-Zalabani AH, Wesselius A, Yi-Wen Yu E, van den Brandt P, Grant EJ, White E, et al. (2022). Tea consumption and risk of bladder cancer in the Bladder Cancer Epidemiology and Nutritional Determinants (BLEND) Study: Pooled analysis of 12 international cohort studies. Clin Nutr. 41(5): 1122-1130. https://doi.org/10.1016/j.clnu.2022.03.020 PMID: 35413574
106. Basu P, Carvalho AL, Almonte M, Chajes V, Weiderpass E (2022). Pulling the investment levers on implementation research in oncology. Lancet Oncol. 23(4): 451-452. https://doi.org/10.1016/S1470-2045(22)00025-0 PMID: 35358451
107. Berndt SI, Vijai J, Benavente Y, Camp NJ, Nieters A, Wang Z, et al. (2022). Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes. Leukemia. 36(12): 2835-2844. https://doi.org/10.1038/s41375-022-01711-0 PMID: 36273105
108. Bertrand KA, O’Brien KM, Wright LB, Palmer JR, Blot WJ, Eliassen AH, et al. (2022). Gestational diabetes and risk of breast cancer before age 55 years. Int J Epidemiol. 50(6): 1936-1947. https://doi.org/10.1093/ije/dyab165 PMID: 34458915
109. Boot IWA, Wesselius A, Yu EYW, Brinkman M, van den Brandt P, Grant EJ, et al. (2022). Dietary B group vitamin intake and the bladder cancer risk: a pooled analysis of prospective cohort studies. Eur J Nutr. 61(5): 2397-2416. https://doi.org/10.1007/s00394-022-02805-2 PMID: 35129646
110. Cairat M, Rinaldi S, Navionis AS, Romieu I, Biessy C, Viallon V, et al. (2022). Circulating inflammatory biomarkers, adipokines and breast cancer risk-a case-control study nested within the EPIC cohort. BMC Med. 20(1): 118. https://doi.org/10.1186/s12916-022-02319-y PMID: 35430795
111. Casalone E, Birolo G, Pardini B, Allione A, Russo A, Catalano C, et al. (2022). Serum Extracellular Vesicle-Derived microRNAs as Potential Biomarkers for Pleural Mesothelioma in a European Prospective Study. Cancers (Basel). 15(1): 15. https://doi.org/10.3390/cancers15010125 PMID: 36612122
112. Cayssials V, Buckland G, Crous-Bou M, Bonet C, Weiderpass E, Skie G, et al. (2022). Inflammatory potential of diet and pancreatic cancer risk in the EPIC study. Eur J Nutr. 61(5): 2313-2320. https://doi.org/10.1007/s00394-022-02809-y PMID: 35091827
113. Charvat H, Freisling H, Noh H, Gaudet MM, Gunter MJ, Cross AJ, et al. (2022). Excess Body Fatness during Early to Mid-Adulthood and Survival from Colorectal and Breast Cancer: A Pooled Analysis of Five International Cohort Studies. Cancer Epidemiol Biomarkers Prev. 31(2): 325-333. https://doi.org/10.1158/1055-9965.EPI-21-0688 PMID: 34782393
114. Clasen JL, Heath AK, Van Puyvelde H, Huybrechts I, Park JY, Ferrari P, et al. (2022). Biomarkers of the transsulfuration pathway and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Int J Cancer. 151(5): 708-716. https://doi.org/10.1002/ijc.34009 PMID: 35366005
115. Cordova R, Mayen AL, Knaze V, Aglago EK, Schalkwijk C, Wagner KH, et al. (2022). Dietary intake of advanced glycation endproducts (AGEs) and cancer risk across more than 20 anatomical sites: A multinational cohort study. Cancer Commun (Lond). 42(10): 1041-1045. https://doi.org/10.1002/cac2.12343 PMID: 35924960
116. Dam V, Onland-Moret NC, Burgess S, Chirlaque MD, Peters SAE, Schuit E, et al. (2022). Genetically Determined Reproductive Aging and Coronary Heart Disease: A Bidirectional 2-sample Mendelian Randomization. J Clin Endocrinol Metab. 107(7): e2952-e2961. https://doi.org/10.1210/clinem/dgac171 PMID: 35306566
117. Dianatinasab M, Wesselius A, Salehi-Abargouei A, Yu EYW, Fararouei M, Brinkman M, et al. (2022). Dietary fats and their sources in association with the risk of bladder cancer: A pooled analysis of 11 prospective cohort studies. Int J Cancer. 151(1): 44-55. https://doi.org/10.1002/ijc.33970 PMID: 35182086
118. Dimou N, Omiyale W, Biessy C, Viallon V, Kaaks R, O’Mara TA, et al. (2022). Cigarette Smoking and Endometrial Cancer Risk: Observational and Mendelian Randomization Analyses. Cancer Epidemiol Biomarkers Prev. 31(9): 1839-1848. https://doi.org/10.1158/1055-9965.EPI-21-1176 PMID: 35900194
119. Dong C, Chan SSM, Jantchou P, Racine A, Oldenburg B, Weiderpass E, et al. (2022). Meat Intake Is Associated with a Higher Risk of Ulcerative Colitis in a Large European Prospective Cohort Studyo. J Crohns Colitis. 16(8): 1187-1196. https://doi.org/10.1093/ecco-jcc/jjac054 PMID: 35396592
120. Ellingjord-Dale M, Christakoudi S, Weiderpass E, Panico S, Dossus L, Olsen A, et al. (2022). Long-term weight change and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Int J Epidemiol. 50(6): 1914-1926. https://doi.org/10.1093/ije/dyab032 PMID: 34999853
121. Fiolet T, Casagrande C, Nicolas G, Horvath Z, Frenoy P, Weiderpass E, et al. (2022). Dietary intakes of dioxins and polychlorobiphenyls (PCBs) and breast cancer risk in 9 European countries. Environ Int. 163: 107213. https://doi.org/10.1016/j.envint.2022.107213 PMID: 35364416
122. Fortuin-de Smidt MC, Sewe MO, Lassale C, Weiderpass E, Andersson J, Huerta JM, et al. (2022). Physical activity attenuates but does not eliminate coronary heart disease risk amongst adults with risk factors: EPIC-CVD case-cohort study. Eur J Prev Cardiol. 29(12): 1618-1629. https://doi.org/10.1093/eurjpc/zwac055 PMID: 35403197
123. Gaziano L, Sun L, Arnold M, Bell S, Cho K, Kaptoge SK, et al. (2022). Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses. Circulation. 146(20): 1507-1517. https://doi.org/10.1161/CIRCULATIONAHA.122.060700 PMID: 36314129
124. Gil-Lespinard M, Castaneda J, Almanza-Aguilera E, Gomez JH, Tjonneland A, Kyro C, et al. (2022). Dietary Intake of 91 Individual Polyphenols and 5-Year Body Weight Change in the EPIC-PANACEA Cohort. Antioxidants (Basel). 11(12). https://doi.org/10.3390/antiox11122425 PMID: 36552633
125. Grenville ZS, Noor U, His M, Viallon V, Rinaldi S, Aglago EK, et al. (2022). Diet and BMI Correlate with Metabolite Patterns Associated with Aggressive Prostate Cancer. Nutrients. 14(16): 3306. https://doi.org/10.3390/nu14163306 PMID: 36014812
126. Hadji M, Rashidian H, Marzban M, Naghibzadeh-Tahami A, Gholipour M, Mohebbi E, et al. (2022). Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran. Int J Epidemiol. 51(3): 830-838. https://doi.org/10.1093/ije/dyac031 PMID: 35244716
127. Harbs J, Rinaldi S, Gicquiau A, Keski-Rahkonen P, Mori N, Liu X, et al. (2022). Circulating Sex Hormone Levels and Colon Cancer Risk in Men: A Nested Case-Control Study and Meta-Analysis. Cancer Epidemiol Biomarkers Prev. 31(4): 793-803. https://doi.org/10.1158/1055-9965.EPI-21-0996 PMID: 35086823
128. Hasanpour-Heidari S, Ahmadi A, Mansuri S, Qorbani A, Semnani S, Fazel A, et al. (2022). Development of an online cancer data collection and processing tool for population-based cancer registries in a low-resource setting: The CanDCap experience from Golestan, Iran. Int J Med Inform. 166: 104846. https://doi.org/10.1016/j.ijmedinf.2022.104846 PMID: 35981480
129. Heath AK, Muller DC, van den Brandt PA, Critselis E, Gunter M, Vineis P, et al. (2022). Diet-wide association study of 92 foods and nutrients and lung cancer risk in the European Prospective Investigation into Cancer and Nutrition study and the Netherlands Cohort Study. Int J Cancer. 151(11): 1935-1946. https://doi.org/10.1002/ijc.34211 PMID: 35830197
130. Hosseini B, Olsson A, Bouaoun L, Hall A, Hadji M, Rashidian H, et al. (2022). Lung cancer risk in relation to jobs held in a nationwide case-control study in Iran. Occup Environ Med. 79(12): 831-838. https://doi.org/10.1136/oemed-2022-108463 PMID: 36379677
131. Iglesias-Vazquez L, Arija V, Aranda N, Aglago EK, Cross AJ, Schulze MB, et al. (2022). Factors associated with serum ferritin levels and iron excess: results from the EPIC-EurGast study. Eur J Nutr. 61(1): 101-114. https://doi.org/10.1007/s00394-021-02625-w PMID: 34213605
132. Iguacel I, Perez-Cornago A, Schmidt JA, Van Puyvelde H, Travis R, Casagrande C, et al. (2022). Evaluation of protein and amino acid intake estimates from the EPIC dietary questionnaires and 24-h dietary recalls using different food composition databases. Nutr Metab Cardiovasc Dis. 32(1): 80-89. https://doi.org/10.1016/j.numecd.2021.09.012 PMID: 34696945
133. Kliemann N, Ould Ammar R, Biessy C, Gicquiau A, Katzke V, Kaaks R, et al. (2022). Metabolically Defined Body Size Phenotypes and Risk of Endometrial Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Epidemiol Biomarkers Prev. 31(7): 1359-1367. https://doi.org/10.1158/1055-9965.EPI-22-0160 PMID: 35437568
134. Kohls M, Freisling H, Charvat H, Soerjomataram I, Viallon V, Davila-Batista V, et al. (2022). Impact of cumulative body mass index and cardiometabolic diseases on survival among patients with colorectal and breast cancer: a multi-centre cohort study. BMC Cancer. 22(1): 546. https://doi.org/10.1186/s12885-022-09589-y PMID: 35568802
135. Lecuyer L, Laouali N, Dossus L, Shivappa N, Hebert JR, Agudo A, et al. (2022). Inflammatory potential of the diet and association with risk of differentiated thyroid cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Eur J Nutr. 61(7): 3625-3635. https://doi.org/10.1007/s00394-022-02897-w PMID: 35635567
136. Liang C, Chung HF, Dobson AJ, Hayashi K, van der Schouw YT, Kuh D, et al. (2022). Infertility, recurrent pregnancy loss, and risk of stroke: pooled analysis of individual patient data of 618 851 women. BMJ. 377: e070603. https://doi.org/10.1136/bmj-2022-070603 PMID: 35732311
137. Llaha F, Cayssials V, Farras M, Agudo A, Sandstrom M, Eriksen AK, et al. (2022). Adherence to mediterranean diet and the risk of differentiated thyroid cancer in a European cohort: The EPIC study. Front Nutr. 9: 982369. https://doi.org/10.3389/fnut.2022.982369 PMID: 36118743
138. Mafra da Costa A, Hernandes ICP, Weiderpass E, Soerjomataram I, Fregnani J (2022). Cancer Statistics over Time in Northwestern Sao Paulo State, Brazil: Incidence and Mortality. Cancer Epidemiol Biomarkers Prev. 31(4): 707-714. https://doi.org/10.1158/1055-9965.EPI-21-0842 PMID: 35131883
139. Mayen AL, Viallon V, Botteri E, Proust-Lima C, Bagnardi V, Batista V, et al. (2022). A longitudinal evaluation of alcohol intake throughout adulthood and colorectal cancer risk. Eur J Epidemiol. 37(9): 915-929. https://doi.org/10.1007/s10654-022-00900-6 PMID: 36063305
140. Mendes-Santos C, Nunes F, Weiderpass E, Santana R, Andersson G (2022). Development and Evaluation of the Usefulness, Usability, and Feasibility of iNNOV Breast Cancer: Mixed Methods Study. JMIR Cancer. 8(1): e33550. https://doi.org/10.2196/33550 PMID: 35166682
141. Mendes-Santos C, Nunes F, Weiderpass E, Santana R, Andersson G (2022). Understanding Mental Health Professionals’ Perspectives and Practices Regarding the Implementation of Digital Mental Health: Qualitative Study. JMIR Form Res. 6(4): e32558. https://doi.org/10.2196/32558 PMID: 35412459
142. Mukama T, Fortner RT, Katzke V, Hynes LC, Petrera A, Hauck SM, et al. (2022). Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancer. Br J Cancer. 126(9): 1301-1309. https://doi.org/10.1038/s41416-021-01697-z PMID: 35031764
143. Nemati S, Saeedi E, Lotfi F, Nahvijou A, Mohebbi E, Ravankhah Z, et al. (2022). National surveillance of cancer survival in Iran (IRANCANSURV): Analysis of data of 15 cancer sites from nine population-based cancer registries. Int J Cancer. 151(12): 2128-2135. https://doi.org/10.1002/ijc.34224 PMID: 35869869
144. Pakmanesh H, Anvari O, Forey N, Weiderpass E, Malekpourafshar R, Iranpour M, et al. (2022). TERT Promoter Mutations as Simple and Non-Invasive Urinary Biomarkers for the Detection of Urothelial Bladder Cancer in a High-Risk Region. Int J Mol Sci. 23(22): 14319. https://doi.org/10.3390/ijms232214319 PMID: 36430798
145. Papadimitriou N, Bouras E, van den Brandt PA, Muller DC, Papadopoulou A, Heath AK, et al. (2022). A Prospective Diet-Wide Association Study for Risk of Colorectal Cancer in EPIC. Clin Gastroenterol Hepatol. 20(4): 864-873 e813. https://doi.org/10.1016/j.cgh.2021.04.028 PMID: 33901663
146. Peluso M, Munnia A, Russo V, Galli A, Pala V, Schouw YTV, et al. (2022). Cruciferous Vegetable Intake and Bulky DNA Damage within Non-Smokers and Former Smokers in the Gen-Air Study (EPIC Cohort). Nutrients. 14(12). https://doi.org/10.3390/nu14122477 PMID: 35745207
147. Perrier F, Ghiasvand R, Lergenmuller S, Robsahm TE, Green AC, Borch KB, et al. (2022). Life-Course Trajectories of Physical Activity and Melanoma Risk in a Large Cohort of Norwegian Women. Clin Epidemiol. 14: 1571-1584. https://doi.org/10.2147/CLEP.S382454 PMID: 36578536
148. Persson MSM, Yin W, Doring N, Risnes K, Weiderpass E, Steliarova-Foucher E, et al. (2022). Gestational age and cancer risk up to young adulthood in Swedish population born 1974 to 2013: A population-based cohort study. Int J Cancer. 150(8): 1269-1280. https://doi.org/10.1002/ijc.33886 PMID: 34855204
149. Pham TT, Nimptsch K, Aleksandrova K, Jenab M, Reichmann R, Wu K, et al. (2022). Pre-Diagnostic Circulating Resistin Concentrations Are Not Associated with Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition Study. Cancers (Basel). 14(22): 5499. https://doi.org/10.3390/cancers14225499 PMID: 36428592
150. Porta M, Gasull M, Pumarega J, Kiviranta H, Rantakokko P, Raaschou-Nielsen O, et al. (2022). Plasma concentrations of persistent organic pollutants and pancreatic cancer risk. Int J Epidemiol. 51(2): 479-490. https://doi.org/10.1093/ije/dyab115 PMID: 34259837
151. Robbins HA, Ferreiro-Iglesias A, Waterboer T, Brenner N, Nygard M, Bender N, et al. (2022). Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium. J Clin Oncol. 40(31): 3613-3622. https://doi.org/10.1200/JCO.21.01785 PMID: 35700419
152. Robinson N, Casement J, Gunter MJ, Huybrechts I, Agudo A, Barranco MR, et al. (2022). Anti-cancer therapy is associated with long-term epigenomic changes in childhood cancer survivors. Br J Cancer. 127(2): 288-300. https://doi.org/10.1038/s41416-022-01792-9 PMID: 35354948
153. Rothwell JA, Murphy N, Besevic J, Kliemann N, Jenab M, Ferrari P, et al. (2022). Metabolic Signatures of Healthy Lifestyle Patterns and Colorectal Cancer Risk in a European Cohort. Clin Gastroenterol Hepatol. 20(5): e1061-e1082. https://doi.org/10.1016/j.cgh.2020.11.045 PMID: 33279777
154. Smith-Byrne K, Cerani A, Guida F, Zhou S, Agudo A, Aleksandrova K, et al. (2022). Circulating Isovalerylcarnitine and Lung Cancer Risk: Evidence from Mendelian Randomization and Prediagnostic Blood Measurements. Cancer Epidemiol Biomarkers Prev. 31(10): 1966-1974. https://doi.org/10.1158/1055-9965.EPI-21-1033 PMID: 35839461
155. Stepien M, Lopez-Nogueroles M, Lahoz A, Kuhn T, Perlemuter G, Voican C, et al. (2022). Prediagnostic alterations in circulating bile acid profiles in the development of hepatocellular carcinoma. Int J Cancer. 150(8): 1255-1268. https://doi.org/10.1002/ijc.33885 PMID: 34843121
156. Taziki M, Rajaei S, Firouzei G, Hashemzadeh F, Rajabalian M, Mansoury M, et al. (2022). Five-year relative survival and determinants of excess mortality in patients with head and neck and thyroid cancers: A population-based study from Golestan province, Northern Iran. Cancer Epidemiol. 80: 102247. https://doi.org/10.1016/j.canep.2022.102247 PMID: 36081275
157. Townsend MK, Trabert B, Fortner RT, Arslan AA, Buring JE, Carter BD, et al. (2022). Cohort Profile: The Ovarian Cancer Cohort Consortium (OC3). Int J Epidemiol. 51(3): e73-e86. https://doi.org/10.1093/ije/dyab211 PMID: 34652432
158. Ugai T, Sasamoto N, Lee HY, Ando M, Song M, Tamimi RM, et al. (2022). Is early-onset cancer an emerging global epidemic? Current evidence and future implications. Nat Rev Clin Oncol. 19(10): 656-673. https://doi.org/10.1038/s41571-022-00672-8 PMID: 36068272
159. Veljkovikj I, Ilbawi AM, Roitberg F, Luciani S, Barango P, Corbex M, et al. (2022). Evolution of the joint International Atomic Energy Agency (IAEA), International Agency for Research on Cancer (IARC), and WHO cancer control assessments (imPACT Reviews). Lancet Oncol. 23(10): e459-e468. https://doi.org/10.1016/S1470-2045(22)00387-4 PMID: 36174632
160. Vissers LET, Sluijs I, Burgess S, Forouhi NG, Freisling H, Imamura F, et al. (2022). Milk intake and incident stroke and CHD in populations of European descent: a Mendelian randomisation study. Br J Nutr. 128(9): 1789-1797. https://doi.org/10.1017/S0007114521004244 PMID: 34670632
161. Watts EL, Perez-Cornago A, Fensom GK, Smith-Byrne K, Noor U, Andrews CD, et al. (2022). Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia. Int J Cancer. 151(7): 1033-1046. https://doi.org/10.1002/ijc.34116 PMID: 35579976
162. Wedekind R, Rothwell JA, Viallon V, Keski-Rahkonen P, Schmidt JA, Chajes V, et al. (2022). Determinants of blood acylcarnitine concentrations in healthy individuals of the European Prospective Investigation into Cancer and Nutrition. Clin Nutr. 41(8): 1735-1745. https://doi.org/10.1016/j.clnu.2022.05.020 PMID: 35779425
163. Zhang L, Carvalho AL, Mosquera I, Wen T, Lucas E, Sauvaget C, et al. (2022). An international consensus on the essential and desirable criteria for an ‘organized’ cancer screening programme. BMC Med. 20(1): 101. https://doi.org/10.1186/s12916-022-02291-7 PMID: 35317783